Bone glue is a surgical adhesive used to attach bones, cartilage, tissue and other structures during orthopedic procedures to help in faster healing. It provides strong fixation of bones, acts as an effective adjunct to standard fixation devices, and helps avoid additional invasive procedures. The global Bone Glue Market is estimated to be valued at US$ 2,332.0 Mn in 2023 and is expected to exhibit a CAGR of 5.9% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.
Market key trends:
Advancements in bone glue technology: Innovations pertaining to the composition of bone glue formulations are expected to accelerate market growth over the forecast period. Researchers are developing new bone glue formulations that mimic the inorganic components of natural bone and have enhanced adhesive strength. They are incorporating components like hydroxyapatite and calcium phosphate to improve osteoconductivity. Development of formulations that set and adhere quickly as well as exhibit higher viscosity for better handling is further boosting the adoption of bone glue in complex surgical procedures. This key trend of ongoing innovations is expected to fuel revenue growth of the bone glue market.
Segment Analysis
Bone glue materials are predominantly categorized into synthetic and natural adhesives. Currently, natural bone glue dominates the market owing to its biocompatibility and ability to induce natural bone healing. However, synthetic glue materials are expected to gain traction over the forecast period attributed to their long-lasting bonding properties and reduced risk of disease transmission as compared to animal or human-derived glues. Synthetic glues can be further divided into polymer-based and calcium-based bone glues. Polymer-based bone glues hold the major market share currently due to their widespread adoption.
Key Takeaways
The global bone glue market is expected to witness high growth over the forecast period. Factors such as increasing number of trauma injuries and accident cases, rising geriatric population prone to bone-related issues, and the growing adoption of minimally invasive procedures are expected to propel the market forward.
Regional analysis
North America currently dominates the bone glue market driven by supportive reimbursement policies and advanced healthcare infrastructure in the region. However, Asia Pacific is identified as the fastest growing regional market attributed to improving healthcare spending, rising medical tourism, and increasing burden of orthopedic disorders in developing Asia Pacific countries.
Key players
Key players operating in the bone glue market are Cryolife, Luna Innovations Incorporated, St. Jude Medical, Inc. (Abbott Laboratories), Johnson and Johnson, Cohera Medical Inc, Tissuemed Ltd., Integra Lifesciences Corporation, Baxter International Inc., B.Braun Melsungen AG, DENTSPLY SIRONA Inc., Chemence Medical Inc., LaunchPad Medical, and C.R. Bard Inc. Companies are engaged in new product launches and geographic expansion to strengthen their market position.
No comments:
Post a Comment